AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32614723 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular physiotherapy (PT) and gaming
Number of subjects: 32
Study 32614723 — intervention group
Group type: COMPARATOR
Intervention: Regular physiotherapy (PT)
Number of subjects: 32
Study 35771851 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (singing lessons)
Number of subjects: 135
Study 35771851 — intervention group
Group type: COMPARATOR
Intervention: Physical activity (active control)
Number of subjects: 135
Study 35771851 — intervention group
Group type: COMPARATOR
Intervention: No intervention (passive control)
Number of subjects: 135
Study 32912861 — intervention group
Group type: EXPERIMENTAL
Intervention: Current (past 7 day) use of HTP at baseline
Number of subjects: 1213
Study 32912861 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent HTP users from baseline to 1‐month/3‐month follow‐up
Number of subjects: 1213
Study 32912861 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of smoking cessation service between baseline and 3‐month follow‐up
Number of subjects: 1213
Study 34957385 — intervention group
Group type: EXPERIMENTAL
Intervention: FTC/TDF+COLCH+ROSU
Number of subjects: 649
Study 34957385 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 649
Study 34957385 — intervention group
Group type: EXPERIMENTAL
Intervention: FTC/TDF
Number of subjects: 649
Study 34957385 — intervention group
Group type: EXPERIMENTAL
Intervention: COLCH+ROSU
Number of subjects: 649
Study 35972301 — intervention group
Group type: EXPERIMENTAL
Intervention: CMO pharmaceutical intervention model
Number of subjects: 100
Study 35972301 — intervention group
Group type: COMPARATOR
Intervention: Regular treatment (Control Group)
Number of subjects: 100
Study 32021152 — intervention group
Group type: EXPERIMENTAL
Intervention: St. George's Respiratory Questionnaire (SGRQ)
Number of subjects: 0
Study 32021152 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D
Number of subjects: 0
Study 33517434 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity human patient simulator
Number of subjects: 61
Study 33517434 — intervention group
Group type: COMPARATOR
Intervention: Control group (no simulation method)
Number of subjects: 61
Study 32108263 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (2640 IU/d)
Number of subjects: 113
Study 32108263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study 34709147 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated metrics‐based summative feedback
Number of subjects: 24
Study 34709147 — intervention group
Group type: COMPARATOR
Intervention: Standard instructions
Number of subjects: 24
Study 33460358 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐min light‐intensity walking every 30 min
Number of subjects: 21
Study 33460358 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐min light‐intensity walking every 60 min
Number of subjects: 21
Study 33460358 — intervention group
Group type: COMPARATOR
Intervention: Prolonged sitting (SIT)
Number of subjects: 21
Study 35470371 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline plus naltrexone
Number of subjects: 26
Study 35470371 — intervention group
Group type: COMPARATOR
Intervention: Varenicline plus placebo
Number of subjects: 26
Study 33851765 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) using Gallium‐aluminum‐arsenide (GaAlAs) diode laser, applied immediately after surgery and for 15 days.
Number of subjects: 93
Study 33851765 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PBMT treatment).
Number of subjects: 93
Study 35915472 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate induction of labor
Number of subjects: 185
Study 35915472 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 185
Study 35915472 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate induction of labor or Expectant management
Number of subjects: 185
Study 33518080 — intervention group
Group type: COMPARATOR
Intervention: 0 mg ALA/bird per day
Number of subjects: 42
Study 33518080 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg ALA/bird per day
Number of subjects: 42
Study 33518080 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg ALA/bird per day
Number of subjects: 42
Study 33518080 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 mg ALA/bird per day
Number of subjects: 42
Study 33518080 — intervention group
Group type: EXPERIMENTAL
Intervention: 95 mg ALA/bird per day
Number of subjects: 42
Study 33518080 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg ALA/bird per day
Number of subjects: 42
Study 33518080 — intervention group
Group type: EXPERIMENTAL
Intervention: 145 mg ALA/bird per day
Number of subjects: 42
Study 35745214 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 supplementation (1 × 10^10 CFU)
Number of subjects: 72
Study 35745214 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (same product without probiotics)
Number of subjects: 72
Study 33789145 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanocurcumin
Number of subjects: 80
Study 33789145 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32388067 — intervention group
Group type: EXPERIMENTAL
Intervention: Locking Plate (LP)
Number of subjects: 20
Study 32388067 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Hip Screw (DHS)
Number of subjects: 20
Study 32388067 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Lag Screw (MLS)
Number of subjects: 20
Study 32388067 — intervention group
Group type: EXPERIMENTAL
Intervention: DHS + MLS (mixed fixture)
Number of subjects: 20
Study 32388067 — intervention group
Group type: EXPERIMENTAL
Intervention: HemiArthroplasty (HA)
Number of subjects: 20
Study 34120232 — intervention group
Group type: EXPERIMENTAL
Intervention: FERAK brace
Number of subjects: 38
Study 34120232 — intervention group
Group type: COMPARATOR
Intervention: Denis Browne boot (DBB) brace
Number of subjects: 38
Study 32621538 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral vestibular disorders overall
Number of subjects: 59986
Study 32621538 — intervention group
Group type: EXPERIMENTAL
Intervention: Meniere's disease
Number of subjects: 59986
Study 32621538 — intervention group
Group type: EXPERIMENTAL
Intervention: Benign paroxysmal positional vertigo
Number of subjects: 59986
Study 32621538 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular neuritis
Number of subjects: 59986
Study 32621538 — intervention group
Group type: EXPERIMENTAL
Intervention: Other or unspecified peripheral vestibular dizziness
Number of subjects: 59986
Study 32621538 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender ratios for Meniere's disease
Number of subjects: 59986
Study 32621538 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender ratios for vestibular neuritis
Number of subjects: 59986
Study 32621538 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender ratios for other peripheral vestibular dizziness
Number of subjects: 59986
Study 32621538 — intervention group
Group type: EXPERIMENTAL
Intervention: Urbanization levels
Number of subjects: 59986
Study 35298696 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam rolling
Number of subjects: 38
Study 35298696 — intervention group
Group type: COMPARATOR
Intervention: Stretching
Number of subjects: 38
Study 34388977 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of urine and breath samples
Number of subjects: 246
Study 34388977 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine samples only
Number of subjects: 246
Study 34388977 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath samples only
Number of subjects: 246
Study 36454263 — intervention group
Group type: EXPERIMENTAL
Intervention: GalNAc3-conjugated 2'-O-methoxyethyl-modified ASOs
Number of subjects: 642
Study 36454263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 642
Study 33595409 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 ppm QY
Number of subjects: 480
Study 33595409 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 ppm QY
Number of subjects: 480
Study 33595409 — intervention group
Group type: COMPARATOR
Intervention: 0 ppm QY (Control)
Number of subjects: 480
Study 33595409 — intervention group
Group type: EXPERIMENTAL
Intervention: All QY treatments (250 and 500 ppm)
Number of subjects: 480
Study 32163557 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorambucil-obinutuzumab (ClbG)
Number of subjects: 0
Study 32163557 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax-obinutuzumab (VenG)
Number of subjects: 0
Study 34785484 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone-sized screen
Number of subjects: 52
Study 34785484 — intervention group
Group type: COMPARATOR
Intervention: Laptop-sized screen
Number of subjects: 52
Study 34388515 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 119
Study 34388515 — intervention group
Group type: COMPARATOR
Intervention: Lomustine
Number of subjects: 119
Study 33231663 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized magnesium sulfate (n = 410)
Number of subjects: 818
Study 33231663 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5.5% saline) (n = 408)
Number of subjects: 818
Study 34360464 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint interval training (SIT) under normobaric normoxia (SL: PIO2 150 mmHg, FIO2 0.209)
Number of subjects: 19
Study 34360464 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint interval training (SIT) under moderate hypoxia (MH: PIO2 117 mmHg, FIO2 0.154)
Number of subjects: 19
Study 34360464 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint interval training (SIT) under severe hypoxia (SH: PIO2 87 mmHg, FIO2 0.112)
Number of subjects: 19
Study 32595060 — intervention group
Group type: EXPERIMENTAL
Intervention: GLASS Ⅰ, Ⅱ, and Ⅲ groups (Endovascular treatment)
Number of subjects: 257
Study 32595060 — intervention group
Group type: EXPERIMENTAL
Intervention: GLASS Ⅲ (Endovascular treatment)
Number of subjects: 257
Study 32595060 — intervention group
Group type: EXPERIMENTAL
Intervention: GLASS scoring system (Endovascular treatment)
Number of subjects: 257
Study 32595060 — intervention group
Group type: EXPERIMENTAL
Intervention: GLASS score groups (Endovascular treatment)
Number of subjects: 257
Study 32595060 — intervention group
Group type: EXPERIMENTAL
Intervention: Development group (Endovascular treatment)
Number of subjects: 257
Study 32595060 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation sample (Endovascular treatment)
Number of subjects: 257
Study 36274468 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage for 3 days, twice a day, for 15 minutes
Number of subjects: 60
Study 36274468 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 36274468 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage
Number of subjects: 60
Study 34629461 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal femoral triangle and distal adductor canal blocks
Number of subjects: 77
Study 34629461 — intervention group
Group type: COMPARATOR
Intervention: Femoral nerve block
Number of subjects: 77
Study 33002305 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung metastasectomy
Number of subjects: 93
Study 33002305 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lung metastasectomy)
Number of subjects: 93
Study 32742507 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (twice daily with a maximum of 180 mmHg for 5 days)
Number of subjects: 200
Study 32742507 — intervention group
Group type: COMPARATOR
Intervention: Cuff inflation to 30 mmHg (sham preconditioning)
Number of subjects: 200
Study 32742507 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning
Number of subjects: 200
Study 34009847 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS with various electrode montages
Number of subjects: 16
Study 34009847 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 16
Study 34636151 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial-onset LN (<12 months after development of SLE, n=49)
Number of subjects: 66
Study 34636151 — intervention group
Group type: COMPARATOR
Intervention: Delayed-onset LN (≥12 months after development of SLE, n=17)
Number of subjects: 66
Study 32700292 — intervention group
Group type: EXPERIMENTAL
Intervention: Gross motor skills assessment (Korper Koordinationstest für Kinder and Bruininks‐Oseretsky Test of Motor Proficiency ‐ 2nd Edition)
Number of subjects: 80
Study 32700292 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular fitness assessment (20‐meter Shuttle Run Test)
Number of subjects: 80
Study 32700292 — intervention group
Group type: EXPERIMENTAL
Intervention: VSWM-related brain activation
Number of subjects: 80
Study 32700292 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral results
Number of subjects: 80
Study 36041773 — intervention group
Group type: EXPERIMENTAL
Intervention: ICS withdrawal
Number of subjects: 40
Study 36041773 — intervention group
Group type: COMPARATOR
Intervention: Usual care (ICS continuation)
Number of subjects: 40
Study 32437332 — intervention group
Group type: EXPERIMENTAL
Intervention: ID + IL-12 (1.6 mg ID + 0.4 mg pIL-12)
Number of subjects: 89
Study 32437332 — intervention group
Group type: EXPERIMENTAL
Intervention: IM + IL-12 (8 mg IM + 1 mg pIL-12)
Number of subjects: 89
Study 32437332 — intervention group
Group type: EXPERIMENTAL
Intervention: ID no IL-12 (1.6 mg ID)
Number of subjects: 89
Study 32437332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 32437332 — intervention group
Group type: EXPERIMENTAL
Intervention: ID + IL-12
Number of subjects: 89
Study 32437332 — intervention group
Group type: EXPERIMENTAL
Intervention: IM + IL-12
Number of subjects: 89
Study 35975728 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (specific intervention not detailed)
Number of subjects: 0
Study 35975728 — intervention group
Group type: COMPARATOR
Intervention: Multimodal telemedicine approach (as mentioned in a referenced trial)
Number of subjects: 0
Study 33439265 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimagrumab (10 mg/kg up to 1200 mg in 5% dextrose solution) every 4 weeks for 48 weeks
Number of subjects: 75
Study 33439265 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% dextrose solution) every 4 weeks for 48 weeks
Number of subjects: 75
Study 33439265 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimagrumab
Number of subjects: 75
Study 33439265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 35253125 — intervention group
Group type: COMPARATOR
Intervention: Discharge on postoperative day (POD) 2
Number of subjects: 1391
Study 35253125 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge on postoperative day (POD) 3
Number of subjects: 1391
Study 35253125 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge on postoperative day (POD) ≥4
Number of subjects: 1391
Study 33387632 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level tragus stimulation (LLTS)
Number of subjects: 50
Study 33387632 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 50
Study 32315969 — intervention group
Group type: EXPERIMENTAL
Intervention: Comic book-based educational program (autonomous reading and character interpretation methodology)
Number of subjects: 83
Study 32315969 — intervention group
Group type: EXPERIMENTAL
Intervention: Character interpretation methodology
Number of subjects: 83
Study 32315969 — intervention group
Group type: EXPERIMENTAL
Intervention: Three months follow-up
Number of subjects: 83
Study 34333237 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative detectable ctDNA
Number of subjects: 23
Study 34333237 — intervention group
Group type: COMPARATOR
Intervention: Postoperative undetectable ctDNA
Number of subjects: 23
Study 32359940 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical fatigue condition
Number of subjects: 19
Study 32359940 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 19
Study 36206262 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic acetaminophen and ibuprofen every 6 hours for 72 hours
Number of subjects: 284
Study 36206262 — intervention group
Group type: COMPARATOR
Intervention: Usual care (acetaminophen every 6 hours for a temperature ≥ 38.5°C)
Number of subjects: 284
Study 33909484 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror illusion
Number of subjects: 0
Study 33909484 — intervention group
Group type: EXPERIMENTAL
Intervention: No mirror illusion
Number of subjects: 0
Study 33909484 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 35484523 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit + behavioral counselling
Number of subjects: 120
Study 35484523 — intervention group
Group type: COMPARATOR
Intervention: Fitbit-only control group
Number of subjects: 120
Study 34554693 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-shot thoracic paravertebral block combined with intravenous analgesia (Group P)
Number of subjects: 96
Study 34554693 — intervention group
Group type: COMPARATOR
Intervention: Continuous thoracic epidural analgesia (Group E)
Number of subjects: 96
Study 35894828 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep hypothermic circulatory arrest (DHCA)
Number of subjects: 320
Study 35894828 — intervention group
Group type: COMPARATOR
Intervention: DHCA/retrograde cerebral perfusion (RCP)
Number of subjects: 320
Study 35894828 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral perfusion strategy
Number of subjects: 320
Study 32815436 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 3 mg
Number of subjects: 0
Study 32815436 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 7 mg
Number of subjects: 0
Study 32815436 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 14 mg
Number of subjects: 0
Study 32815436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32815436 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide
Number of subjects: 0
Study 34483453 — intervention group
Group type: COMPARATOR
Intervention: Placebo short-wave diathermy
Number of subjects: 90
Study 34483453 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous short-wave diathermy
Number of subjects: 90
Study 34483453 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed short-wave diathermy
Number of subjects: 90
Study 36408818 — intervention group
Group type: EXPERIMENTAL
Intervention: HELENA-IR index scores for males
Number of subjects: 1053
Study 36408818 — intervention group
Group type: EXPERIMENTAL
Intervention: HELENA-IR index scores for females
Number of subjects: 1053
Study 34195628 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 tablets of hydrocodone (10 mg)–acetaminophen (325 mg)
Number of subjects: 85
Study 34195628 — intervention group
Group type: COMPARATOR
Intervention: 60 tablets of hydrocodone (10 mg)–acetaminophen (325 mg)
Number of subjects: 85
Study 33503882 — intervention group
Group type: EXPERIMENTAL
Intervention: Smell and taste of milk before gastric tube feeds (n = 16)
Number of subjects: 35
Study 33503882 — intervention group
Group type: COMPARATOR
Intervention: No exposure (control group, n = 19)
Number of subjects: 35
Study 33503882 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric tube feeds
Number of subjects: 35
Study 33503882 — intervention group
Group type: EXPERIMENTAL
Intervention: Smell of milk
Number of subjects: 35
Study 32580739 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent preventive therapy during pregnancy
Number of subjects: 228
Study 33530956 — intervention group
Group type: EXPERIMENTAL
Intervention: Techniques for managing impacted fetal head at caesarean section
Number of subjects: 0
Study 33530956 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed choice in trials
Number of subjects: 0
Study 33530956 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive antenatal and postpartum education
Number of subjects: 0
Study 32427120 — intervention group
Group type: EXPERIMENTAL
Intervention: omega-3 and cetirizine
Number of subjects: 52
Study 32427120 — intervention group
Group type: COMPARATOR
Intervention: cetirizine
Number of subjects: 52
Study 36216423 — intervention group
Group type: EXPERIMENTAL
Intervention: HABIT intervention delivered by trained Health Visitors
Number of subjects: 35
Study 34028494 — intervention group
Group type: EXPERIMENTAL
Intervention: Online communication training for clinicians (3 sequential online educational modules and weekly text messages)
Number of subjects: 29206
Study 34028494 — intervention group
Group type: EXPERIMENTAL
Intervention: Online communication training for clinicians
Number of subjects: 29206
Study 34028494 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 29206
Study 36216902 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrupted suture technique (IST)
Number of subjects: 332
Study 36216902 — intervention group
Group type: COMPARATOR
Intervention: Continuous suture technique (CST)
Number of subjects: 332
Study 34404983 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam monotherapy
Number of subjects: 129
Study 34404983 — intervention group
Group type: COMPARATOR
Intervention: Midazolam plus fentanyl
Number of subjects: 129
Study 35801782 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-based caregiver education (WBCE) program
Number of subjects: 170
Study 35801782 — intervention group
Group type: COMPARATOR
Intervention: Control care (CC) group
Number of subjects: 170
Study 34255136 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplementation (3 g daily)
Number of subjects: 16
Study 34255136 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplementation + exercise
Number of subjects: 16
Study 34255136 — intervention group
Group type: COMPARATOR
Intervention: Taurine supplementation
Number of subjects: 16
Study 32176191 — intervention group
Group type: EXPERIMENTAL
Intervention: Do CHANGE 2 intervention (ambulatory health-behavior assessment technologies for 6 months combined with a 3-month behavioral intervention program)
Number of subjects: 150
Study 32176191 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 150
Study 35841235 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA vaccine (M group; n = 43)
Number of subjects: 85
Study 35841235 — intervention group
Group type: COMPARATOR
Intervention: Viral vector vaccine (V group; n = 42)
Number of subjects: 85